Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

650
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
650
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

343
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
343
Neural Regulation01:37

Neural Regulation

39.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K
Brainstem01:19

Brainstem

2.6K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
2.6K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

22
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
22

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxidized High-Density Lipoprotein and Cardiovascular Risk in Rheumatoid Arthritis.

Journal of clinical medicine research·2026
Same author

Observational Retrospective Cohort of Patient Support Program Data on Practical Experiences of Treatment with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: The ORCHESTRA Study.

Neurology and therapy·2026
Same author

Cough reflex testing for dysphagia severity and pneumonia risk after acute stroke: a prospective observational study.

Stroke and vascular neurology·2026
Same author

A multidisciplinary Delphi consensus on the formulation of an optimized oral diet for dysphagia and malnutrition (FOOD-DM).

Clinical nutrition (Edinburgh, Scotland)·2026
Same author

Preventing Parkinson's disease in the context of movement disorders: a narrative review of current evidence and future directions.

Neurological research and practice·2026
Same author

Actually, what is a gain-of-function mutation?

Genetics·2026

Related Experiment Video

Updated: Aug 18, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.7K

[Parkinson's disease].

Tobias Warnecke1,2,3, Carina Lummer4, Johannes Wilhelm Rey5

  • 1Klinik für Neurologie und Neurologische Frührehabilitation, Klinikum Osnabrück, Am Finkenhügel 1, 49076, Osnabrück, Deutschland. tobias.warnecke@klinikum-os.de.

Innere Medizin (Heidelberg, Germany)
|December 8, 2022
PubMed
Summary

Parkinson's disease management is improving with new diagnostic criteria and understanding of gut-brain interactions. Multidisciplinary care and novel treatments enhance symptom control and quality of life for patients.

Keywords:
DementiaDysphagiaGeriatricsParkinson networksParkinsonian syndromes

More Related Videos

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.9K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.1K

Related Experiment Videos

Last Updated: Aug 18, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.7K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

3.9K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.1K

Area of Science:

  • Neurodegenerative Disorders
  • Gastroenterology
  • Geriatrics

Context:

  • Parkinson's disease (PD) management requires multidisciplinary collaboration, including neurologists, general practitioners, gastroenterologists, and geriatricians.
  • Evolving diagnostic criteria for PD and atypical Parkinsonism incorporate non-motor symptoms for earlier detection.
  • Complex interactions between PD and the gastrointestinal tract are increasingly understood, impacting treatment strategies.

Purpose:

  • To highlight the importance of integrated care in managing Parkinson's disease.
  • To emphasize the role of novel diagnostic approaches and understanding of gastrointestinal involvement.
  • To discuss advancements in treatment, particularly dopaminergic therapies, and specialized care for geriatric patients with PD.

Summary:

  • Parkinson's disease is a neurodegenerative disorder with effective management strategies focused on sustained symptom control and improved quality of life.
  • Optimized PD management involves collaboration among various medical specialists and incorporates new diagnostic criteria that include non-motor symptoms for early diagnosis.
  • Understanding the intricate relationship between PD and the gastrointestinal tract has led to innovative treatment approaches, including novel dopaminergic therapies designed to bypass gastrointestinal impairment.

Impact:

  • Improved patient outcomes through early diagnosis and comprehensive, multidisciplinary care.
  • Advancement of Parkinson's disease as a model for developing network-based treatments for chronic neurological conditions.
  • Enhanced quality of life for Parkinson's disease patients, including specialized approaches for geriatric populations and those with dementia.